Akero Therapeutics, Inc. (AKRO)

Akero Therapeutics Stock Forecast

Stock Price Forecast

The 9 analysts that cover Akero Therapeutics stock have a consensus rating of "Buy" and an average price target of $73.56, which forecasts a 35.72% increase in the stock price over the next year. The lowest target is $54 and the highest is $109.

Price Target: $73.56 (+35.72%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$54	$73.56	$75	$109
Change	-0.37%	+35.72%	+38.38%	+101.11%

Analyst Ratings

The average analyst rating for Akero Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	May '25	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25
Strong Buy	5	5	5	6	7	5
Buy	3	3	3	1	1	1
Hold	0	0	0	0	0	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	7	8	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andy Chen Wolfe Research	Wolfe Research	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Oct 10, 2025
Andrew S. Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades $72 → $54	Strong Buy → Hold	Downgrades	$72 → $54	-0.37%	Oct 10, 2025
Andrew Tsai Jefferies	Jefferies	Strong Buy → Hold Downgrades $75 → $56	Strong Buy → Hold	Downgrades	$75 → $56	+3.32%	Oct 9, 2025
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy → Hold Downgrades $73 → $54	Strong Buy → Hold	Downgrades	$73 → $54	-0.37%	Oct 9, 2025
Andrew S. Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $72	Strong Buy	Initiates	$72	+32.84%	Sep 4, 2025

More Analyst Ratings

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  n/a
• EPS This Year:
  -3.72

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-2.52	-2.89	-2.87	-2.89	-3.75	-3.72	-4.20
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	11	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-3.76	-4.07
Avg	-3.72	-4.20
Low	-3.86	-4.31

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.